Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...

Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty segment's lackluster ...

Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...

NEW YORK (Reuters) - Starboard Value called consumer products company Kenvue a bargain and said its skin health and beauty ...

Shares of consumer-products company Kenvue Inc. rose the most in more than two months after activist investor Starboard Value took a stake in the Tylenol maker with an eye toward making changes to ...

Activist investor Starboard Value, which picked up a $1 billion stake in Pfizer earlier this month, now reportedly has ...

Some of the steam is coming out of Wall Street’s record-breaking rally, as U.S. stocks edge back from their all-time highs.

Activist investor Starboard Value reportedly has taken a large stake in consumer health products maker Kenvue.

Wall Street tipped toward losses before the open as markets gird for another busy week of corporate earnings reports. Futures ...

Activist hedge fund Starboard Value has reportedly taken a stake in Kenvue, sparking a pre-market stock surge.

Kenvue shares jumped premarket after The Wall Street Journal reported that Starboard Value has taken a sizable stake in the ...

AI search startup Perplexity aims for $8B valuation in new round. UBS sells 50% interest in Swisscard to Amex - report.